1. Home
  2. ADPT vs CENTA Comparison

ADPT vs CENTA Comparison

Compare ADPT & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • CENTA
  • Stock Information
  • Founded
  • ADPT 2009
  • CENTA 1955
  • Country
  • ADPT United States
  • CENTA United States
  • Employees
  • ADPT N/A
  • CENTA N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • CENTA Consumer Specialties
  • Sector
  • ADPT Health Care
  • CENTA Consumer Discretionary
  • Exchange
  • ADPT Nasdaq
  • CENTA Nasdaq
  • Market Cap
  • ADPT 1.8B
  • CENTA 2.1B
  • IPO Year
  • ADPT 2019
  • CENTA 1993
  • Fundamental
  • Price
  • ADPT $12.61
  • CENTA $32.35
  • Analyst Decision
  • ADPT Strong Buy
  • CENTA Buy
  • Analyst Count
  • ADPT 8
  • CENTA 4
  • Target Price
  • ADPT $12.38
  • CENTA $37.00
  • AVG Volume (30 Days)
  • ADPT 1.8M
  • CENTA 350.5K
  • Earning Date
  • ADPT 11-06-2025
  • CENTA 08-06-2025
  • Dividend Yield
  • ADPT N/A
  • CENTA N/A
  • EPS Growth
  • ADPT N/A
  • CENTA N/A
  • EPS
  • ADPT N/A
  • CENTA 2.14
  • Revenue
  • ADPT $205,216,000.00
  • CENTA $3,120,375,000.00
  • Revenue This Year
  • ADPT $32.76
  • CENTA N/A
  • Revenue Next Year
  • ADPT $15.81
  • CENTA $0.16
  • P/E Ratio
  • ADPT N/A
  • CENTA $14.95
  • Revenue Growth
  • ADPT 21.60
  • CENTA N/A
  • 52 Week Low
  • ADPT $3.98
  • CENTA $27.70
  • 52 Week High
  • ADPT $13.68
  • CENTA $37.35
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 51.14
  • CENTA 42.90
  • Support Level
  • ADPT $12.34
  • CENTA $32.76
  • Resistance Level
  • ADPT $13.68
  • CENTA $34.88
  • Average True Range (ATR)
  • ADPT 0.56
  • CENTA 0.76
  • MACD
  • ADPT -0.08
  • CENTA 0.01
  • Stochastic Oscillator
  • ADPT 20.15
  • CENTA 10.60

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: